Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Lumera Corporation to Exhibit at PEGS in Boston May 14-18

Abstract:
The Protein Engineering Summit

Lumera Corporation to Exhibit at PEGS in Boston May 14-18

BOTHELL, WA | Posted on May 7th, 2007

Lumera Corporation (NASDAQ:LMRA), a leader in the emerging field of nanotechnology, announced today that it will be exhibiting at the Protein Engineering Summit 2007 (PEGS). The conference is being held in Boston and begins on Monday, May 14, 2007, and continues through Friday, May 18, 2007.

In addition, Ron Dudek, Lumera's Director of Business Development, will be giving a luncheon workshop presentation on Monday, May 14, entitled "Surface Plasmon Resonance (SPR) Analysis of High-Density Antibody Microarrays: Combining Antibody Screening and Kinetic Characterization in One Platform." Additional information on the conference can be obtained at http://www.pegsummit.com/ .

####

About Lumera Corporation
Lumera is a leader in the emerging field of nanotechnology. The company designs proprietary molecular structures and polymer compounds for the bioscience and communications/computing industries, both of which represent large market opportunities. The company also has developed proprietary processes for fabricating such devices. For more information, please visit http://www.lumera.com .

Certain statements contained in this release are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company’s forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified from time to time in the company’s SEC reports, including its Annual Report on Form 10-K, and its Quarterly Reports on Form 10-Q.

For more information, please click here

Contacts:
The Summit Group Communications
Todd Wolfenbarger
801-595-1155
Cell: 801-244-9600

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

Efficiency of Nanodrug Containing Antibiotics in Treatment of Infectious Diseases Evaluated August 31st, 2015

Seeing quantum motion August 30th, 2015

Artificial leaf harnesses sunlight for efficient fuel production August 30th, 2015

Researchers use DNA 'clews' to shuttle CRISPR-Cas9 gene-editing tool into cells August 30th, 2015

Events/Classes

Nanometrics to Participate in the Citi 2015 Global Technology Conference August 26th, 2015

Developing Component Scale Composites Using Nanocarbons August 26th, 2015

Nanotechnology that will impact the Security & Defense sectors to be discussed at NanoSD2015 conference August 25th, 2015

Abstract Submission Deadline for “2nd International Conference on Infectious Diseases & Nanomedicine (December 15-18, 2015, Kathmandu, NEPAL)” has been extended to Sept 15. August 20th, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic